Bicycle Therapeutics PLC (FRA:50BA)
€ 22 0 (0%) Market Cap: 1.52 Bil Enterprise Value: 692.51 Mil PE Ratio: 0 PB Ratio: 2.02 GF Score: 75/100

Bicycle Therapeutics PLC at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 02:30PM GMT
Release Date Price: €23.2
Kelly Shi
Jefferies LLC - Analyst

(audio in progress) everyone. My name is Kelly Shi, one of the biotech analysts at the Jefferies, and thank you for attending Jefferies New York Healthcare Conference. And in this session, we are very pleased to have a biotech team. And we have Kevin Lee, CEO and also -- who's sitting on the stage; and Nick Keen, CSO; and also Santiago Arroyo, CDO. And they joined the fireside chat session.

Questions & Answers

Kelly Shi
Jefferies LLC - Analyst

And to start off, Kevin, maybe you can give the audience who are not as super familiar with the story, like what's unique about your technology platform?

Kevin Lee
Bicycle Therapeutics plc - CEO

Absolutely. First of all, many thanks for the invitation to be here today, Kelly. Really appreciate it. So Bicycle is a company that was founded by Sir Greg Winter, Nobel Prize winner for his work in peptides and antibodies. It's based on a completely novel technology, which is a -- that is constrained peptides.

So bicycles are

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot